Effect of a lactose-free milk formula supplemented with bifidobacteria and streptococci on the recovery from acute diarrhoea;Chinese Source

Asia Pacific Journal of Clinical Nutrition

Volumn 17, Issue 1, 2008, Pages 30-34

  Mao, Meng ^a   Yu, Tao ^a   Xiong, Ying ^a   Wang, Zhiling ^a   Liu, Hanmin ^a   Gotteland, Martin ^b   Brunser, Oscar ^b  

^a WEST CHINA UNIVERSITY OF MEDICAL SCIENCES   (China)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Acute diarrhoea; Bifidobacterium lactis Bb12; Infants; Probiotics; Rotavirus

Indexed keywords

BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS; ROTAVIRUS; STREPTOCOCCUS;

LACTOSE; PROBIOTIC AGENT;

ACUTE DISEASE; ARTICLE; BACTERIAL COUNT; BIFIDOBACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE TRANSMISSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INFANT; MALE; METABOLISM; PHYSIOLOGY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS; TIME; TREATMENT OUTCOME; VIROLOGY; VIRUS INFECTION; VIRUS SHEDDING;

ACUTE DISEASE; BIFIDOBACTERIUM; CHILD, PRESCHOOL; COLONY COUNT, MICROBIAL; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; LACTOSE; MALE; PROBIOTICS; ROTAVIRUS INFECTIONS; STREPTOCOCCUS; TIME FACTORS; TREATMENT OUTCOME; VIRUS SHEDDING;

EID: 51649117354     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dennehy PH. Acute diarrheal disease in children: epidemiology, prevention, and treatment. Infect Dis Clin North Am. 2005;19:585-602.
2. Scrimshaw NS, SanGiovanni JP. Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr. 1997;66:464S-477S.
3. Metchnikoff E. The prolongation of life. NY, Putnam Sons, 1908.
4. Fuller R. Probiotics in human medicine. Gut. 1991;32: 439-442.
5. Solis B, Samartin S, Gomez S, Nova E, de la Rosa B, Marcos A. Probiotics as a help in children suffering from malnutrition and diarrhoea. Eur J Clin Nutr. 2002;56 (Suppl 3): S57-S59.
6. Cummings JH, Antoine JM, Azpiroz F, Bourdet-Sicard R, Brandtzaeg P, Calder PC, Gibson GR, Guarner F, Isolauri E, Pannemans D, Shortt C, Tuijtelaars S, Watzl B. PASSCLAIM--gut health and immunity. Eur J Nutr. 2004;43 (Suppl 2):II118-II173.
7. Doré J, Rigottier-Gois L. Flore microbienne intestinale. Méthodes d'étude. In: Rambaud JC, Buts JP, Corthier G, Flourié B, Editors. Flore microbienne intestinales. Physiologie et pathologies digestives. Montrouge: John Libbey Eurotext 2004. p 3-17.
8. Garrido D, Suau A, Pochart P, Cruchet S, Gotteland M. Modulation of the fecal microbiota by the intake of a Lactobacillus johnsonii La1-containing product in human volunteers. FEMS Microbiol Lett. 2005;248:249-256.
9. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet. 1994;344:1046-1049.
10. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics. 1991;88:90-97.
11. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res. 1992;32:141-144.
12. Szajewska H, Setty M, Mrukowicz J, Guandalini S. Probiotics in gastrointestinal diseases in children: hard and not-sohard evidence of efficacy. J Pediatr Gastroenterol Nutr. 2006; 42:454-475.
13. Gudmand-Hoyer E. The clinical significance of disaccharide maldigestion. Am J Clin Nutr. 1994;59(Suppl):735S-741S.
14. Pochart P, Dewit O, Desjeux JF, Bourlioux P. Viable starter culture, beta-galactosidase activity, and lactose in duodenum after yogurt ingestion in lactase-deficient humans. Am J Clin Nutr. 1989;49:828-831.
15. Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, Jiang B, Gentsch JR. Rotavirus vaccines: current prospects and future challenges. Lancet. 2006;368:323-332.
16. Tannock GW. Introduction. In: Probiotics. A critical Review. Tannock GW, Ed. Norfolk: Horizon Scientific Press, 1999. pp 1-4.
17. Duffy LC, Zielezny MA, Riepenhoff-Talty M, Dryja D, Sayahtaheri-Altaie S, Griffiths E, Ruffin D, Barrett H, Ogra PL. Reduction of virus shedding by B. bifidum in experimentally induced MRV infection. Statistical application for ELISA. Dig Dis Sci. 1994;39:2334-2340.
18. Shu Q, Qu F, Gill HS. Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. J Pediatr Gastroenterol Nutr. 2001;33:171-177.
19. Phuapradit P, Varavithya W, Vathanophas K, Sangchai R, Podhipak A, Suthutvoravut U, Nopchinda S, Chantraruksa V, Haschke F. Reduction of rotavirus infection in children receiving bifidobacteria-supplemented formula. J Med Assoc Thai. 1999;82 (Suppl 1):S43-S48.
20. Collado MC, Jalonen L, Meriluoto J, Salminen S. Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus. Asia Pac J Clin Nutr. 2006;15:570-575.